ReviewRadiologie (Heidelberg, Germany)2026
[Primary malignant bone tumours-part II].
Review in Radiologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chondrosarcomas are tumours that typically occur in older adults. Although a few arise de novo, they often develop from pre-existing enchondromas, much more frequently from osteochondromas. In these secondary chondrosarcomas, the primary site of pre-existing chondrogenic lesion plays an important role (close to the trunk, centrally; appendicular skeleton, peripherally). Thus, low-grade chondrosarcomas in the periphery are referred to as atypical chondrogenic tumours (ACT), whereas tumours of the same histopathological type located close to the axial skeleton are called chondrosarcoma grade 1. Syndromal occurrence (Ollier's and Maffucci's diseases) carries a significantly higher risk of malignant transformation. Other malignant primary bone tumours being much less frequent exhibit an unspecific osteolytic morphology but sometimes at a typical location (chordoma: sacrococcygeal region; adamantinoma: tibial shaft; malignant giant-cell tumor [GCT]: epi-metaphyseal expansion). Subsequent histological evaluation frequently reveals the (unexpected) diagnosis. For this reason, one section will focus on tumour mimics and differentiation from benign bone lesions. In this respect, some associated aspects of the well-known Lodwick (Madewell) classifications are discussed in order to highlight three very peculiar bone tumour-associated imaging phenomena (periosteal reactions, aneurysmatic bone cyst-like changes, peritumoral reactive zones).
Indexed as
Identifiers
42113187What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.